Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indo US Bio-Tech Limited Board/Management Information 2026

Apr 22, 2026

60794_rns_2026-04-22_ac6bccf1-995a-4b3e-8835-83febdd84366.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [426 x 84] intentionally omitted <==

Date: 22-04-2026

BSE Limited National Stock Exchange of India Limited Dept. of Corporate Services, Dept. of Corporate Compliances, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G, Dalal Street, Bandra Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 BSE Scrip Code - 541304 NSE Symbol: INDOUS

Dear Sir/Madam,

Sub: - Revised Intimation of Appointment of Additional Director in the capacity of NonExecutive Independent Director Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref. Query mail dated 22[nd] April, 2026

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company has appointed the following Director on the Board of the Company by passing resolution on 21.04.2026 pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015: -

Appointment of Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director in the capacity of Non-Executive Independent Director Mrs. Hemanshi Darsh Soni (DIN: 11659183) has been appointed as an Additional Director in the capacity of Non-Executive Independent Director for a period of 5 years w.e.f. 21.04.2026 subject to approval of Shareholders in General Meeting. Mrs. Hemanshi Darsh Soni (DIN: 11659183) is not related to any of the Directors/ Key Managerial Personnel of the Company.

Details required under Regulation 30 of the Listing Regulations read with applicable SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, in respect of appointment of Directors, are enclosed herewith as Annexure A.

Please take the above on record and oblige.

Thanking You,

Yours Faithfully,

For, INDO US BIOTECH LIMITED

Jagdish Digitally signed by Jagdish Devaji Ajudia Date: 2026.04.22 16:50:38 Devaji Ajudia +05'30' ________________________________ Mr. Jagdish Ajudiya Managing Director (DIN: 01745951)

==> picture [426 x 104] intentionally omitted <==

==> picture [426 x 84] intentionally omitted <==

Annexure A

Details as required under SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

==> picture [425 x 338] intentionally omitted <==

----- Start of picture text ----- Sr. No. Particular Details1. Reason for change Mrs. Hemanshi Darsh Soni (DIN: 11659183) has beenviz. appointment, appointed as an Additional Director in the capacity of Non-re-appointment, Executive Independent Director.resignation ,removal, death orotherwise2. Date of 21.04.2026Appointment, re-appointment, Cession(as applicable) reappointment3. Terms of For a period of 5 years w.e.f. 21.04.2026 subject to approval ofAppointment Shareholders.4. Brief Profile Mrs. Hemanshi Darsh Soni is in service sector and known for(In case of building high-performance teams, implementing strong sales,Appointment) marketing and service networks and putting in place robustoperational processes.5. Disclosure of Mrs. Hemanshi Darsh Soni (DIN: 11659183) is not related torelationship between any director on the Board of the Company.Directors (In case ofAppointment)6. Directorship in any Mrs. Hemanshi Darsh Soni does not hold directorship in anyother Entity other listed entity.7. Affirmation (not Mrs. Hemanshi Darsh Soni is not debarred from holding thedebarred) office of Director by virtue of any SEBI order or any other suchauthority.----- End of picture text -----

==> picture [426 x 104] intentionally omitted <==